Labs continue to lack the resources necessary to meet the demands for timely COVID-19 testing. In July, industry groups called on the White House to take control and resolve, or at least allay the … [Read more...]
Testing Strategy
Labs to HHS: Since We Can’t COVID-19 Test Everyone, Let Us Prioritize the Symptomatic
September 4, 2020
Test Utilization
Rapid Testing the Linchpin of COVID-19 Contact Tracing Effectiveness
July 27, 2020
Without rapid testing and results, COVID-19 contact tracing will not work. That is the conclusion of a new study published in The Lancet. Even the most efficient contact tracing strategy will not … [Read more...]
Conflicts with US Guidelines
The Coronavirus Crisis: Is CT More Effective than Laboratory Testing in Detecting COVID-19?
March 23, 2020
Could it be that we are barking up the wrong tree in terms of how best to diagnose 2019 novel coronavirus COVID-19? Current U.S. guidelines prioritize laboratory testing over computed tomography (CT) … [Read more...]
Money Talks
Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests
March 20, 2020
When it comes to getting physicians not to order low-value laboratory tests, money talks. At least, that is the punchline of a new study finding that changes in payment policies are more effective … [Read more...]
LDTs
Laboratory Developed Tests: The VALID Act is Back
March 18, 2020
With all the attention commanded by the coronavirus crisis, a potentially huge development affecting the future of the lab industry has flown under the radar. What’s at stake is the issue that has … [Read more...]
Emerging Tests: Lab Industry Mobilizes to Develop Coronavirus Detection Test
March 2, 2020
The global coronavirus (COVID-19) outbreak came without warning and is having a seismic impact on laboratories and the diagnostics business. The imperative for the industry right now is to develop a … [Read more...]
EMERGING TESTS
Targeted Genetic Risk-Based Prostate Cancer Screening Would Save the Most Lives at the Best Costs: UK Study
January 19, 2020
Targeted screening of men at high genetic risk of the disease could prevent nearly one in six prostate cancer deaths. That is the tantalizing finding of a new computer modeling study led by the … [Read more...]
FDA WATCH
FDA Watch: Agency Resounds the Alarm on Biotin Test Interference
November 19, 2019
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The … [Read more...]
